Stock listing

KRX:0009K0 Aimed Bio Inc. (에임드바이오) 주가

Follow Aimed Bio Inc. into a list and get an email when it puts out news.

Share price · KRX:0009K0

₩15,150 KRW -780 (-4.9%)

Close on Nov 20, 2026

This year -65.6% · daily closes, Dec 4, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩15,080 – ₩16,000 KRWNov 20, 2026
Volume
183,491 sharesNov 20, 2026
Market cap
₩972.0B KRWAt the close on Nov 20, 2026 · price × 64.16M shares outstanding
Traded on an average day
₩2.70B KRWMedian day 109,984 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Aimed Bio Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:0009K0 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩15,150-780-4.9%₩16,000₩16,000₩15,080183,491
₩15,930-100-0.6%₩16,180₩17,050₩15,830181,083
₩16,030-470-2.8%₩15,990₩16,740₩15,700193,993
₩16,500-1,810-9.9%₩18,520₩18,820₩16,310264,364
₩18,310-900-4.7%₩19,580₩20,600₩18,310219,353
₩19,210-550-2.8%₩19,680₩19,800₩18,95090,967
₩19,760+1,160+6.2%₩18,440₩19,850₩18,440146,017
₩18,600+690+3.9%₩18,340₩19,400₩17,910136,593
₩17,910-340-1.9%₩18,070₩18,760₩17,420122,356
₩18,250-820-4.3%₩17,470₩19,150₩17,190165,356
₩19,070+270+1.4%₩19,200₩20,050₩18,800154,370
₩18,800+440+2.4%₩18,390₩18,800₩17,390191,221
₩18,360-850-4.4%₩18,820₩19,340₩18,300115,426
₩19,210+350+1.9%₩18,690₩19,470₩18,60089,849
₩18,860-990-5.0%₩19,850₩19,850₩18,540151,538
₩19,850-1,000-4.8%₩21,650₩21,850₩19,700246,080
₩20,850+300+1.5%₩20,600₩21,400₩20,550105,916
₩20,550-1,250-5.7%₩22,250₩22,800₩20,450216,320
₩21,800+900+4.3%₩22,200₩23,150₩20,900349,753
₩20,900-450-2.1%₩21,250₩21,600₩20,400103,403
₩21,350-650-3.0%₩21,850₩22,450₩21,150104,630
₩22,000-550-2.4%₩23,000₩23,800₩21,850109,554
₩22,550+350+1.6%₩21,600₩23,150₩21,300104,092
₩22,200+1,400+6.7%₩20,750₩22,400₩20,100118,071
₩20,800+1,620+8.4%₩19,350₩21,500₩19,320114,835
₩19,180-1,570-7.6%₩19,980₩20,200₩18,570136,117
₩20,750+50+0.2%₩20,850₩21,350₩20,40099,021
₩20,700-1,500-6.8%₩21,350₩21,800₩20,000156,824
₩22,200-2,050-8.5%₩24,200₩24,500₩21,800105,076
₩24,250-1,650-6.4%₩25,650₩25,750₩24,050116,369
₩25,900+100+0.4%₩26,150₩26,450₩25,550108,074
₩25,800+1,000+4.0%₩25,200₩26,450₩25,100157,625
₩24,800-650-2.6%₩25,400₩25,900₩24,250106,646
₩25,450+3,100+13.9%₩22,100₩25,600₩22,000231,943
₩22,350+850+4.0%₩21,500₩22,600₩21,150100,076
₩21,500-850-3.8%₩22,100₩22,150₩20,800110,414
₩22,350+950+4.4%₩22,200₩22,900₩22,000119,817
₩21,400+200+0.9%₩21,150₩21,700₩20,90085,923
₩21,200-450-2.1%₩21,850₩22,150₩20,900133,603
₩21,650-100-0.5%₩21,550₩21,850₩21,150105,991
₩21,750-900-4.0%₩22,650₩22,750₩21,550248,033
₩22,650+50+0.2%₩22,950₩23,200₩22,35071,019
₩22,60000.0%₩22,350₩22,700₩22,00054,287
₩22,600+450+2.0%₩22,350₩23,000₩22,20068,413
₩22,150-500-2.2%₩22,050₩22,400₩21,65080,334
₩22,650-1,050-4.4%₩22,700₩23,100₩22,45074,187
₩23,700+100+0.4%₩23,500₩23,700₩22,60085,447
₩23,600-100-0.4%₩23,300₩24,250₩23,20054,439
₩23,700-550-2.3%₩24,050₩24,300₩23,60069,355
₩24,250+800+3.4%₩23,650₩24,300₩23,25061,792
₩23,450+1,050+4.7%₩22,600₩23,850₩22,55074,543
₩22,400-800-3.4%₩23,850₩24,000₩22,20091,031
₩23,200-550-2.3%₩23,000₩24,400₩22,750114,869
₩23,750-750-3.1%₩24,300₩24,800₩23,500105,857
₩24,500-600-2.4%₩24,200₩25,050₩23,60089,750
₩25,100-600-2.3%₩25,500₩26,250₩24,75081,222
₩25,700+300+1.2%₩25,250₩25,750₩25,10062,254
₩25,400-600-2.3%₩25,950₩26,500₩25,35072,646
₩26,000+50+0.2%₩25,500₩26,050₩24,150102,028
₩25,950+1,450+5.9%₩24,650₩26,450₩24,650130,352
₩24,500-1,950-7.4%₩25,450₩25,650₩24,300110,550
₩26,450+350+1.3%₩27,550₩27,900₩25,850126,370
Ticker
KRX:0009K0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Aimed Bio Inc. news

Aimed Bio Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Feb 6, 2026 · oldest 2025

Valuation

P/E 25.2× against a median of 9.8×: the highest of 4 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩879.3B KRW
P/E
25.2×
EV/sales
13.2×
EV/EBITDA
34.0×
Price/book
4.8×
Gross margin
100.0%
Operating margin
36.3%
Net margin
57.8%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Aimed Bio Inc. · KRX:0009K0US$722.1MUS$653.2M25.2×13.2×34.0×4.8×57.8%0.0×n/a
MeiraGTx Holdings plc · NASDAQ:MGTXUS$766.4MUS$715.6M9.8×1.8×3.7×3.6×19.5%0.6×1.57
ORIC Pharmaceuticals, Inc. · NASDAQ:ORICUS$764.9MUS$503.6Mn/an/an/a2.3×n/a0.0×1.22
Inventiva SA · EURONEXT:IVAUS$760.9MUS$577.3Mn/a117×n/a11.8×n/a1.1×n/a
Rigel Pharmaceuticals, Inc. · NASDAQ:RIGLUS$754.9MUS$663.4M2.5×2.3×8.3×1.7×106.6%0.0×1.02
Obsidian Therapeutics, Inc. · NASDAQ:OBXUS$741.3MUS$530.4M13.0×n/an/a2.3×n/a0.0×n/a
Monte Rosa Therapeutics, Inc. · NASDAQ:GLUEUS$738.3MUS$196.8Mn/a2.8×n/a1.5×−186.2%0.1×0.92
Aura Biosciences, Inc. · NASDAQ:AURAUS$715.0MUS$433.9Mn/an/an/a2.5×n/a0.1×1.07
Solid Biosciences Inc. · NASDAQ:SLDBUS$697.6MUS$368.3Mn/an/an/a2.0×n/a0.1×1.85
Attovia Therapeutics, Inc. · NASDAQ:ATTOUS$689.3MUS$297.2Mn/a220×n/a1.7×n/a0.0×n/a
Lexicon Pharmaceuticals, Inc. · NASDAQ:LXRXUS$681.2MUS$549.9Mn/a14.3×n/a4.2×−161.8%0.3×1.15
Median of the othersUS$739.8MUS$517.0M9.8×8.5×6.0×2.3×−71.2%0.1×1.15

Forecasts

Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.

EPS, year to Dec 2026
170.00 · 1 analyst
Revenue, year to Dec 2026
27.6B · 1 analyst

Financials

Annual, in KRW

Income statement

LineFY2025FY2024
Revenue47.3B11.8B
Gross profit47.3B11.8B
Selling, general and administrative19.5B7.53B
Operating income20.8B-407.8M
Depreciation and amortization1.38B1.46B
EBITDA22.2B1.06B
Interest expense57.0M93.1M
Income before tax-4.16B-3.31B
Net income5.02B-3.30B
Earnings per share, basic78.29-51.50

Balance sheet

LineFY2025FY2024
Cash and equivalents106.4B4.49B
Short-term investments64.4B31.0B
Receivables3.30B
Current assets178.5B36.2B
Total assets199.0B47.1B
Current liabilities5.68B43.6B
Total liabilities6.40B43.8B
Shareholders' equity192.6B3.36B
Shares outstanding64.2M64.2M

Cash flow

LineFY2025FY2024
Cash from operations17.9B-4.87B
Capital spending-362.6M-1.68B
Free cash flow17.5B-6.55B
Change in cash101.9B3.03B

Open Financials

Cap table

Built by 6ix from Aimed Bio Inc.’s releases

Common shares
64,156,161
Fully diluted
64,156,161

Fully diluted

LineShares
Common shares64,156,161

Share count over time

CountShares
Nov 22, 202664,156,161

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund285KUS$4.01MJul 31, 2026
Vanguard Developed Markets Index Fund165KUS$2.7MJun 30, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund95,617US$1.34MJul 31, 2026
Vanguard Pacific Stock Index Fund21,884US$308KJul 31, 2026
Vanguard Total World Stock Index Fund17,589US$247KJul 31, 2026

Big stakes

StakeFiling
에스엠비투자파트너스Large holding report (5%)

Open Shareholders

Log in to ask 6ix AI your own questions about Aimed Bio Inc.